Tempus AI Inc

NASDAQ:TEMUnited States

Tempus AI, Inc. is a technology company. The Company provides next generation diagnostics across multiple disease areas, with technology capabilities, harnessing the data and analytics to help personalize medicine. The Company’s product lines include genomics, data, and artificial intelligence applications (AI). Its genomics product line leverages its laboratories to provide next generation sequencing, diagnostics, polymerase chain reaction (PCR), profiling, molecular genotyping, and other anatomic and molecular pathology testing. The Company's AI applications are focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools. Its primary product of AI applications is Next, an AI platform that leverages machine learning to apply an intelligent layer onto routinely generated data to proactively identify and minimize care gaps for oncology and cardiology patients.

Contact Information

Headquarters

600 West Chicago Avenue, Suite 510CHICAGO, IL, United States 60654

Phone

---

Fax

302-655-5049

Executives

Chief Executive Officer, Director

Eric Lefkofsky

Chief Financial Officer

James Rogers

Chief Operating Officer

Ryan Fukushima

Executive Vice President, Chief Administrative and Legal Officer, Assistant Secretary

Erik Phelps

Executive Vice President, General Counsel

Andrew Polovin